Neuronetics Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -56.6% | 10.5% | -69.0% | -30.2% | -29.2% | -38.2% | -53.1% | -9.2% | -2.1% | 2.2% | -27.3% | 0.4% | -5.9% | |
| 2.8% | 2.5% | 3.2% | 3.4% | 2.8% | 2.0% | 2.8% | 2.4% | 2.4% | 1.8% | 2.2% | 1.8% | 2.0% | |
| 10.4% | 8.0% | 7.7% | 9.5% | 7.7% | 5.7% | 4.5% | 4.8% | 3.8% | 5.2% | 4.9% | 5.7% | 4.9% | |
| -32.2% | 25.5% | -39.3% | 10.6% | 2.7% | -9.8% | -21.4% | 8.2% | 15.3% | 11.0% | -5.3% | 7.2% | 7.4% | |
| 3.1% | 4.3% | 2.2% | 3.7% | 2.1% | 0.4% | 0.7% | 0.7% | 0.3% | 0.5% | 0.6% | 1.0% | 0.6% | |
| 0.4% | -2.8% | 0.4% | -0.7% | 0.1% | -10.6% | -0.7% | -0.7% | -0.3% | -0.5% | -0.5% | -1.0% | -0.6% | |
| – | – | – | – | -64.3% | 41.8% | 0.0% | 0.0% | 26.8% | -0.5% | -14.5% | 0.0% | 3.1% | |
| 0.0% | 109.6% | 0.0% | 0.0% | -88.4% | 42.5% | 59.3% | 0.0% | 48.0% | -2.5% | -16.2% | 37.0% | 17.2% | |
| -56.2% | 117.3% | -68.6% | -30.9% | -117.5% | -6.3% | 5.5% | -9.9% | 45.6% | -0.8% | -44.0% | 36.4% | 10.7% | |
| -59.7% | 6.2% | -71.1% | -34.0% | -31.3% | -38.6% | -53.8% | -9.9% | -2.4% | 1.7% | -27.9% | -0.6% | -6.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.